← Evidence map

ArticleCell cycle (Georgetown, Tex.)2017

Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab.

Elisabet Cuyàs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28387573